201PEfficacy and safety of darolutamide in non-metastatic castration-resistant prostate cancer (nmCRPC) in the ARAMIS trial J S-T Pang,N Shore,M R Smith,T L Tammela,A Ulys,E Vjaters,S Polyakov,M Jievaltas,M Luz,B Alekseev,I Kuss,M-A Le Berre,A Snapir,T Sarapohja,K FizaziANNALS OF ONCOLOGY(2019)引用 5|浏览59暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要